tradingkey.logo

Shoulder Innovations Inc

SI
查看详细走势图
15.550USD
+0.230+1.50%
收盘 12/22, 16:00美东报价延迟15分钟
320.09M总市值
亏损市盈率 TTM

Shoulder Innovations Inc

15.550
+0.230+1.50%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.50%

5天

+7.61%

1月

+5.85%

6月

0.00%

今年开始到现在

0.00%

1年

0.00%

查看详细走势图

TradingKey Shoulder Innovations Inc股票评分

单位: USD 更新时间: 2025-12-22

操作建议

Shoulder Innovations Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名142/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价20.60。中期看,股价处于上升通道。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Shoulder Innovations Inc评分

相关信息

行业排名
142 / 208
全市场排名
417 / 4578
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 5 位分析师
买入
评级
20.600
目标均价
+39.38%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Shoulder Innovations Inc亮点

亮点风险
Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
业绩增长期
公司处于发展阶段,最新年度总收入31.62M美元
估值低估
公司最新PE估值-2.18,处于3年历史低位
机构加仓
最新机构持股12.77M股,环比增加42.48%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值146.27K

Shoulder Innovations Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Shoulder Innovations Inc简介

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
公司代码SI
公司Shoulder Innovations Inc
CEOBall (Robert Joseph)
网址https://shoulderinnovations.com/

常见问题

Shoulder Innovations Inc(SI)的当前股价是多少?

Shoulder Innovations Inc(SI)的当前股价是 15.550。

Shoulder Innovations Inc的股票代码是什么?

Shoulder Innovations Inc的股票代码是SI。

Shoulder Innovations Inc股票的52周最高点是多少?

Shoulder Innovations Inc股票的52周最高点是17.940。

Shoulder Innovations Inc股票的52周最低点是多少?

Shoulder Innovations Inc股票的52周最低点是10.920。

Shoulder Innovations Inc的市值是多少?

Shoulder Innovations Inc的市值是320.09M。

Shoulder Innovations Inc的净利润是多少?

Shoulder Innovations Inc的净利润为-13.69M。

现在Shoulder Innovations Inc(SI)的股票是买入、持有还是卖出?

根据分析师评级,Shoulder Innovations Inc(SI)的总体评级为买入,目标价格为20.600。

Shoulder Innovations Inc(SI)股票的每股收益(EPS TTM)是多少

Shoulder Innovations Inc(SI)股票的每股收益(EPS TTM)是-7.096。
KeyAI